The VEGF/VEGFR2 signaling pathway provides tumor cells with the necessary blood supply to support their growth and metastasis, as well as promotes tumor progression through a variety of mechanisms, including influencing the immune microenvironment. The gene discussed is KDR; the disease is neoplasm.